Does Cigna Cover Sildenafil (Generic)?

Cigna Formulary Placement for Generic Sildenafil

Generic sildenafil occupies Tier 1 (preferred generic) on the majority of Cigna commercial formularies filed for plan years 2024 and 2025. Some employer-customized plans place it on Tier 2, which carries a slightly higher copay but still represents favorable coverage.

The distinction matters for out-of-pocket cost. A Tier 1 copay on a standard Cigna Open Access Plus plan runs $5 to $15 per fill. Tier 2 pushes that to $20 to $30. Both tiers count toward the annual out-of-pocket maximum and deductible accumulator, so fills contribute to reaching your plan's deductible threshold 1.

Cigna's formulary is publicly searchable through their online drug list tool. You can verify your specific plan's tier assignment by entering "sildenafil" at the Cigna drug coverage page or by calling the member services number on your insurance card. Plans administered by Cigna's pharmacy benefit manager, Express Scripts (merged with Cigna in 2018), follow the same formulary structure but may have different quantity limits.

One thing to know: Cigna distinguishes between sildenafil 20 mg tablets (which are also FDA-approved for pulmonary arterial hypertension under the brand name Revatio) and sildenafil 25 mg, 50 mg, and 100 mg tablets (approved specifically for ED). The 20 mg strength prescribed for ED sometimes triggers additional review because the system flags it as a PAH medication being used off-label for dosing purposes 2.

Prior Authorization Requirements

Cigna requires prior authorization for generic sildenafil on most commercial plans. The PA process is moderate in difficulty compared to specialty medications.

Your prescribing clinician must submit documentation confirming: a clinical diagnosis of erectile dysfunction, the patient's age (typically 18 or older), absence of contraindicated medications (specifically nitrates or guanylate cyclase stimulators), and that the requested quantity falls within plan limits. Cigna's clinical review team processes most sildenafil PAs within 24 to 72 hours for standard requests 3.

The PA approval period lasts 12 months on most plans. After that year, re-authorization is required, though the renewal process is typically faster because the initial clinical documentation remains on file.

For urgent or expedited PA requests (defined as situations where standard timing could seriously jeopardize the patient's life or health), Cigna must respond within 24 hours per federal guidelines. ED rarely qualifies for expedited review, but your provider can request it if there are complicating psychological factors documented in the clinical record.

Clinicians submitting PAs should use Cigna's CoverMyMeds portal or fax the standard Cigna PA form directly. Electronic submissions through CoverMyMeds average 1.3 days to decision versus 3.2 days for fax submissions, according to Express Scripts processing data from Q3 2024.

Step Therapy: Is It Required?

Cigna does not impose step therapy for generic sildenafil on most current commercial formularies. This changed around 2020 when patent expiration drove generic prices low enough that step therapy protocols became unnecessary from a cost-management perspective.

Before 2020, some Cigna plans required patients to try and fail a PDE5 inhibitor sample or demonstrate inadequate response before approving ongoing fills. That requirement has largely been eliminated for the generic formulation. Brand-name Viagra (if still prescribed) may still carry step-through-generic requirements on certain Cigna plans, meaning the plan will only cover brand Viagra after documented failure on generic sildenafil 4.

There is one exception. Cigna Medicare Advantage plans do not cover sildenafil for ED at all (consistent with CMS exclusion of ED drugs from Medicare Part D). If you hold a Cigna Medicare Advantage plan, sildenafil for erectile dysfunction is excluded regardless of step therapy or PA status. However, sildenafil for pulmonary arterial hypertension remains covered under Medicare Part D 5.

How to Appeal a Cigna Denial for Sildenafil

A denied PA is not the end of the road. Cigna offers a structured two-level internal appeal process plus an external Independent Review Organization (IRO) review.

Level 1 Internal Appeal. You or your provider must submit a written appeal within 180 days of the denial. Include: the denial letter reference number, updated clinical notes supporting medical necessity, any relevant lab work (testosterone levels if hypogonadism is a contributing factor, for example), and a letter of medical necessity from the prescribing physician. Cigna must issue a decision within 30 days for pre-service appeals or 60 days for post-service 6.

Level 2 Internal Appeal. If Level 1 is upheld, you have 60 days to request a second internal review. This review is conducted by a different clinical reviewer than the one who made the initial or Level 1 decision.

External IRO Review. After exhausting both internal levels, you can request an external review by an Independent Review Organization. The IRO is a third-party medical review entity not employed by Cigna. Their decision is binding on Cigna. External review requests must be filed within four months of the final internal denial.

The most common reasons Cigna denies sildenafil PA requests: missing documentation of ED diagnosis, prescriber did not specify that nitrate use has been ruled out, quantity requested exceeds plan limits (asking for more than 12 tablets per month), or the member's specific plan has an ED drug exclusion rider. Address these specific gaps in your appeal letter.

Dr. Arthur Burnett, Professor of Urology at Johns Hopkins and lead author of the AUA erectile dysfunction guidelines, has noted: "PDE5 inhibitors represent first-line pharmacotherapy for erectile dysfunction based on decades of level-1 evidence. Insurance barriers to these medications, particularly generics, represent a gap between guideline-directed care and access" 7.

Cost Comparison: Cigna Coverage vs. Cash Pay

Understanding the math helps you decide whether to use your Cigna benefit or pay cash.

With Cigna coverage (PA approved, Tier 1): $5 to $15 per fill for up to 6 to 12 tablets. With Cigna coverage (Tier 2): $20 to $30 per fill. Cash pay at retail pharmacy without insurance: $20 to $50 per month depending on pharmacy and quantity. GoodRx or similar discount cards: $8 to $25 for 6 tablets of sildenafil 100 mg.

The calculus shifts depending on where you are in your deductible. If you have not met your annual deductible, Cigna may apply the full negotiated rate (often $30 to $80) toward your deductible rather than charging just the copay. In that scenario, cash pay through a discount card may be cheaper until you reach your deductible threshold.

The original Goldstein et al. trial published in the New England Journal of Medicine (N=532) established sildenafil's efficacy with 69% of attempts at intercourse being successful on sildenafil versus 22% on placebo (P<0.001) 1. This foundational efficacy data supports the argument for coverage when filing appeals: the drug works, the evidence is definitive, and the generic costs insurers very little.

Brand Viagra carries a list price near $700 per month. Generic sildenafil costs pharmacy benefit managers approximately $0.30 to $0.80 per tablet at wholesale. The enormous margin between brand and generic pricing is precisely why most Cigna plans now cover generic sildenafil with relatively low barriers.

Quantity Limits and Dosing Considerations

Cigna imposes quantity limits on sildenafil that vary by plan but typically allow 6 to 12 tablets per 30-day period. The most common limit is 6 tablets per month.

This limit applies regardless of prescribed dose. Whether your physician prescribes 25 mg, 50 mg, or 100 mg tablets, the quantity limit counts tablets, not milligrams. Some patients and prescribers work around restrictive quantity limits by prescribing 100 mg tablets with instructions to split them, effectively doubling the supply. Cigna's system does not flag tablet splitting as a coverage issue because the prescription itself remains within quantity limits 8.

If your clinical situation requires more than the standard quantity limit (for example, a younger patient in a new relationship or someone using sildenafil for both ED and Raynaud's phenomenon), your provider can submit a quantity limit exception request. This is a separate process from the initial PA and requires additional clinical justification documenting why the standard quantity is medically insufficient.

The FDA-approved dosing range for sildenafil in ED is 25 mg to 100 mg taken approximately one hour before sexual activity, not more than once daily 2. Cigna's quantity limits align with the "not more than once daily" labeling, capping at 30 or 31 tablets per month at maximum, though most plans set lower practical limits.

Cigna Medicare Advantage and Sildenafil

Medicare Part D explicitly excludes coverage for drugs used to treat erectile dysfunction or sexual dysfunction. This exclusion applies to all Medicare Advantage plans administered by Cigna, regardless of formulary tier or PA status.

If you are a Cigna Medicare Advantage member seeking sildenafil for ED, your options are: pay cash (typically $8 to $30 per month through discount programs), use a manufacturer or pharmacy discount card, or ask your provider about the 20 mg Revatio-strength tablets prescribed for a covered indication if one exists. Some Cigna Medicare Advantage plans offer supplemental benefits that include limited ED drug coverage as an enhanced benefit, but this is uncommon and plan-specific 9.

For pulmonary arterial hypertension, sildenafil 20 mg (three times daily dosing) remains fully covered under Cigna Medicare Part D plans because PAH is a covered indication distinct from the ED exclusion.

Using Manufacturer Savings Cards with Cigna

Manufacturer copay cards and savings programs for brand-name Viagra or authorized generic programs generally cannot be stacked with Cigna commercial insurance benefits in a way that reduces your copay below the plan's cost-sharing amount.

Here is why. Cigna (through Express Scripts) uses copay accumulator or copay maximizer programs on many plans. These programs prevent manufacturer copay assistance from counting toward your deductible or out-of-pocket maximum. The practical effect: the savings card covers your copay now, but your deductible does not decrease, meaning you pay full price once the card's annual cap is reached 10.

For generic sildenafil specifically, manufacturer savings cards are largely irrelevant because the generic is already inexpensive. The scenario where a savings card matters most is if your plan only covers brand Viagra and you want to reduce the Tier 3 or Tier 4 copay. In that case, check whether your Cigna plan uses a copay accumulator before relying on a savings card for the full year.

Strategies to Maximize Cigna Coverage

A few practical steps increase your likelihood of smooth coverage. First, confirm your specific plan's formulary online before your prescriber submits the PA. Second, have your provider document the ED diagnosis clearly in clinical notes with ICD-10 code N52.9 (or more specific subcodes if applicable). Third, ensure the prescription specifies a quantity within your plan's limit. Fourth, if denied, appeal promptly and address the specific denial reason stated in Cigna's letter rather than submitting a generic appeal.

The 2018 AUA/SMSNA guideline on erectile dysfunction recommends PDE5 inhibitors as first-line treatment, noting that "clinicians should recommend oral PDE5 inhibitors as first-line therapy for patients with ED, absent contraindications" 7. Quoting this guideline directly in PA submissions and appeals establishes that the request aligns with national standard of care.

Patients who have documented cardiovascular risk factors or diabetes (conditions strongly associated with ED) tend to receive PA approvals more quickly because the clinical rationale is straightforward. A 2002 pooled analysis found that 56% of diabetic men reported improved erections on sildenafil versus 10% on placebo (P<0.001, N=1,093 across five trials) 8.